Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ikena Oncology, Inc. - Common Stock
(NQ:
IKNA
)
1.570
+0.040 (+2.61%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ikena Oncology, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 23, 2024
Via
Benzinga
Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement
December 23, 2024
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology Reports Third Quarter 2024 Financial Results
November 07, 2024
Strong financial position with $138 million in cash and investments at close of third quarter
From
Ikena Oncology, Inc.
Via
GlobeNewswire
IKNA Stock Earnings: Ikena Oncology Beats EPS for Q2 2024
August 09, 2024
IKNA stock results show that Ikena Oncology beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
The Analyst Landscape: 4 Takes On Ikena Oncology
March 19, 2024
Via
Benzinga
Ikena Oncology: Q4 Earnings Insights
March 12, 2024
Via
Benzinga
Ikena Oncology Reports Second Quarter 2024 Financial Results
August 08, 2024
Strong financial position with $145 million in cash and investments at close of second quarter
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology Discontinues IK-930 Program And Cuts Workforce, Analyst Calls It 'Disappointing'
May 29, 2024
Ikena Oncology halts its IK-930 program after reviewing clinical data and resources, focusing on the novel MEK-RAF molecular glue, IK-595.
Via
Benzinga
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 29, 2024
Via
Benzinga
This American Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
May 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 29, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 29, 2024
It's time to start the day with a breakdown of the biggest pre-market stock movers traders are going to want to watch on Wednesday morning!
Via
InvestorPlace
UPDATE – Ikena Oncology Announces Strategic Update
May 28, 2024
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology Announces Strategic Update
May 28, 2024
From
Ikena Oncology, Inc.
Via
GlobeNewswire
IKNA Stock Earnings: Ikena Oncology Beats EPS for Q1 2024
May 13, 2024
IKNA stock results show that Ikena Oncology beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
May 13, 2024
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
April 10, 2024
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
March 12, 2024
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference
February 27, 2024
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
February 21, 2024
From
Ikena Oncology, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 16, 2024
Via
Benzinga
Ikena Oncology Refocuses on Key Programs: Analysts Maintain Outperform Ratings Amid Strategic Organizational Changes
January 19, 2024
Ikena Oncology optimizes resources for targeted oncology programs IK-930 & IK-595. Clinical updates expected H2 2024. Workforce reduced by 35%. Financially secure with $175M cash. Strategic focus on...
Via
Benzinga
Ikena Oncology Outlines Key Priorities and Provides Corporate Updates
January 18, 2024
From
Ikena Oncology, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
December 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 24, 2023
Via
Benzinga
Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
November 24, 2023
Shares of Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) surged in pre-market trading after the company announced its foray into the Middle Ea
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 17, 2023
Via
Benzinga
Dow Falls Over 200 Points; Krispy Kreme Reports Downbeat Results
November 09, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling over 200 points on Thursday. The Dow traded down 0.71% to 33,871.77 while the NASDAQ fell 0.87% to 13,531.36. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Cancer Firm Ikena Oncology Stock Trading Lower Today?
November 09, 2023
Ikena Oncology Inc (NASDAQ: IKNA) shared initial data from twenty-six patients treated in the ongoing dose escalation portion of the
Via
Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 09, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.